Highlights Diaceutics PLC

Equities

Market Closed - London S.E. Other stock markets 16:35:10 20/05/2024 BST			5-day change	1st Jan Change
118.5 ^GBX	+3.49%		+20.92%	+36.21%

05-16	EARNINGS AND TRADING: Michelmersh continues with positive order intake	AN
05-16	Diaceutics Bags Two Enterprise-wide Engagements with Large Pharmaceutical Companies	MT

EARNINGS AND TRADING: Michelmersh continues with positive order intake	05-16	AN
Diaceutics Bags Two Enterprise-wide Engagements with Large Pharmaceutical Companies	05-16	MT
Diaceutics plc Announces Two New Enterprise-Wide Engagements	05-16	CI
Roadside shares suspended; Adnams looks for funds	04-02	AN
Diaceutics upgrades diagnositc commercialisation platform, DXRX	03-21	AN
Diaceutics PLC Launches Significant Upgrade to Its DXRX Platform	03-21	CI
Sondrel wins USD23 million contract	02-27	AN
Diaceutics Expands Lab Network, Data Coverage in Europe	02-27	MT
Diaceutics announces new marketing partnership with KPMG	02-14	AN
Diaceutics maintains "momentum" for year ahead on revenue rise in 2023	01-30	AN
Diaceutics revenue grows but loss widens, CEO Keeling to step down	26/09/23	AN
Earnings Flash (DXRX.L) DIACEUTICS Posts H1 Revenue GBP9.9M	26/09/23	MT
Diaceutics PLC Reports Earnings Results for the Half Year Ended June 30, 2023	26/09/23	CI
Diaceutics plc Launches Daily Alerts for Dxrx Platform	29/08/23	CI
Diaceutics interim revenue jumps as order book grows to GBP24 million	25/07/23	AN
Diaceutics shares surge on contract win with top US firm	05/06/23	AN
Diaceutics Up 13% Following Three-year Enterprise Contract With Global Pharma Company	05/06/23	MT
Diaceutics PLC Receives USD 10.1 Million Multi-Year Enterprise Engagement with Top 10 Global Pharmaceutical Company	05/06/23	CI
Diaceutics Seeks M&A Opportunities	18/04/23	CI
Diaceutics achieves increase in annual revenue and profit	17/04/23	AN

No results for this search